A 10 billion yuan M&A fund for biomedical industry will also be set up.[Shanghai 10 billion M&A Fund! 】Big move! Two billion M&A and restructuring funds in Shanghai have come to target the chip and pharmaceutical industries.
[Shanghai 10 billion M&A Fund! 】Among them, Chengdu Ruiyuan Semiconductor is mainly engaged in the research and development, design, packaging and sales of power management chips, and one of its main products is DC/DC chips. A-share listed companies include Jingfeng Mingyuan, Fumanwei, Shanghai Beiling and Xidiwei, all of which have certain market share and competitiveness in the DC/DC chip market.Bu Rixin, a partner of Chuangdao Investment Consulting, said in an interview with the science and technology innovation board Journal that the 10 billion M&A fund is mainly aimed at the "integrated circuit design industry", which may be related to the end of the IPO dividend period of chip design companies.
In addition to the integrated circuit design industry, Shanghai will also set up a M&A fund for the biomedical industry with a scale of 10 billion yuan.The policy is favorable for surprise attack and seize the opportunity to get on the bus > >
Strategy guide
12-14
Strategy guide
12-14
Strategy guide
Strategy guide 12-14